Global Biological Glufosinate-Ammonium Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

September 2026 | 94 pages | ID: G66BC367F6D6EN
GlobalInfoResearch

Abstracts

According to our (Global Info Research) latest study, the global Biological Glufosinate-Ammonium market size was valued at US$ 222 million in 2025 and is forecast to a readjusted size of US$ 503 million by 2032 with a CAGR of 10.9% during review period.

Biological Glufosinate-Ammonium refers to technical-grade glufosinate-P produced through biological manufacturing processes in which biocatalysis plays a critical role in stereoselective synthesis, isomer conversion or chiral precursor preparation. The product is based on the herbicidally active L-glufosinate component and is primarily manufactured through enzymatic conversion of racemic glufosinate, fermentation-derived chiral precursor routes or other commercially viable biocatalytic processes. A representative pathway converts the less-active D-isomer in racemic glufosinate into the herbicidally active L-isomer through enzymatic reactions, improving active-isomer utilization and raw-material efficiency. Biological Glufosinate-Ammonium technical material is mainly supplied to pesticide formulators and crop-protection companies for further processing into herbicide formulations used in field crops, horticultural crops, plantation and forestry crops and other weed-control applications.

Key Findings

• China is the principal manufacturing base for Biological Glufosinate-Ammonium technical material
• Enzymatic deracemization is the most representative commercial biomanufacturing route
• Commercial supply is concentrated among a limited number of established technical active ingredient producers
• Field Crops represent the principal downstream application category
• Competition is shifting from process commercialization toward manufacturing cost and operational efficiency

Market Trends

Biological Glufosinate-Ammonium is moving from technology industrialization toward large-scale, integrated and cost-oriented manufacturing. Process development increasingly focuses on improving enzyme activity and stability, increasing substrate concentration, optimizing multi-enzyme reaction systems, extending catalyst life and reducing downstream separation and purification costs. The competitive objective is therefore shifting from achieving high L-isomer selectivity toward lowering overall manufacturing cost while maintaining consistent technical-grade quality. Integration with upstream racemic glufosinate or fermentation-derived chiral precursors is becoming increasingly important, as feedstock availability, intermediate cost and purification efficiency directly influence production economics. Over the longer term, continuous biocatalytic processing, improved enzyme productivity, catalyst reuse and closer integration between biological conversion and chemical processing are expected to remain important directions of technology development.

Market Dynamics

Drivers

The principal market driver is the improved utilization of the herbicidally active L-isomer compared with conventional racemic glufosinate. Biocatalytic conversion can increase the proportion of active L-glufosinate, improving active-ingredient efficiency and supporting more efficient formulation, transportation and application. Demand is also supported by the established role of glufosinate-based herbicides in broad-acre agriculture and other weed-management systems. On the supply side, continued industrialization of enzyme-based processes is reducing scale-up uncertainty and supporting further investment in manufacturing capacity, enzyme engineering and process optimization.

Restraints

Market development remains constrained by the economics and operating complexity of biocatalytic manufacturing. Enzyme preparation, catalyst stability, substrate concentration, conversion efficiency, reaction control and downstream purification all affect production cost. Biological routes also face competition from conventional glufosinate and alternative Glufosinate-P synthesis technologies, placing continued pressure on product pricing and manufacturing margins. Differences in pesticide registration requirements, technical standards and formulation specifications across countries may also increase the time and cost required for technical active ingredient suppliers to expand internationally.

Opportunities

Future opportunities are mainly associated with further substitution of racemic glufosinate, broader adoption of L-glufosinate-based weed-control systems and deeper participation in global crop-protection supply chains. Producers with integrated racemic glufosinate feedstock, proprietary enzyme systems or fermentation-derived chiral intermediates may achieve stronger cost competitiveness through improved raw-material utilization and process efficiency. Long-term technical active ingredient supply, contract manufacturing and technology cooperation with international crop-protection companies also provide opportunities for manufacturers capable of delivering consistent quality, reliable supply and registration support.

Challenges

The industry's long-term challenge is the transition from technology-driven scarcity toward cost-driven competition. As additional biological manufacturing projects enter commercial operation, supply expansion may place greater pressure on capacity utilization, pricing and profitability. Producers need to continuously improve enzyme performance, conversion yield, reaction efficiency and separation economics while maintaining consistent technical quality and optical purity. Intellectual property, biological catalyst protection and accumulated industrial process know-how remain important barriers because apparently similar biocatalytic routes can differ significantly in manufacturing cost, operational stability and scalability.

Industry Chain Analysis

The upstream chain of Biological Glufosinate-Ammonium includes racemic glufosinate and related phosphorus-containing intermediates, L-homoserine and other chiral precursors, enzymes and microbial production systems, fermentation materials, cofactors, auxiliary chemicals, solvents and separation materials. Different manufacturing routes have different upstream requirements. Racemic-glufosinate-based enzymatic conversion benefits from integration with conventional glufosinate production, while fermentation-derived precursor routes place greater emphasis on strain performance, fermentation efficiency and chiral-intermediate economics. Feedstock integration, enzyme productivity and catalyst reuse are therefore important determinants of manufacturing cost and supply stability.

The midstream segment covers enzyme preparation, stereoselective bioconversion, reaction control, separation, purification and standardization of technical active ingredient. This stage represents the core value-creation segment because production economics depend on both conversion efficiency and downstream processing performance. Downstream customers are primarily pesticide formulators and crop-protection companies that convert technical material into registered herbicide formulations. Manufacturers with integrated feedstock supply, stable product quality, industrial-scale production and established customer relationships generally have stronger supply-chain competitiveness.

Segment Insights

By biomanufacturing route, enzymatic deracemization is the most representative commercial pathway, generally using racemic glufosinate as feedstock and converting the less-active D-isomer toward the herbicidally active L-isomer. Fermentation-derived chiral precursor routes represent another important technological direction, while other biocatalytic synthesis methods remain relatively specialized. As industrialization progresses, competition among different routes is increasingly determined by feedstock cost, enzyme or strain productivity, substrate concentration, conversion efficiency and downstream purification requirements rather than technical feasibility alone.

By technical purity, mainstream technical-grade specifications constitute the core of current commercial supply, while higher-purity products mainly serve differentiated requirements. By feedstock route, racemic-glufosinate-based processes currently have the clearest industrial foundation, while L-homoserine and other chiral precursor routes provide alternative integration strategies. By downstream application, Field Crops form the principal demand category; Horticultural Crops cover fruit, vine and vegetable production; Plantation & Forestry Crops cover perennial plantation and forestry applications; and Other includes remaining agricultural and non-crop weed-control uses.

Downstream Market Opportunities

Field Crops represent the most important downstream opportunity for Biological Glufosinate-Ammonium, supported by broad demand for non-selective weed control in soybean, corn, cotton and other large-scale cropping systems. Horticultural Crops provide diversified demand in fruit, vine and vegetable production, while Plantation & Forestry Crops extend the addressable market into perennial production systems and forestry management. Other applications cover remaining agricultural and non-crop weed-control uses. For technical active ingredient manufacturers, future growth will depend primarily on securing long-term formulation customers, supporting product registrations and establishing reliable international supply.

Regional Insights

Production of Biological Glufosinate-Ammonium has historically been concentrated in China and Germany, with China now serving as the principal manufacturing base due to its integrated glufosinate supply chain, biocatalytic engineering capability and large-scale agrochemical manufacturing infrastructure. Germany was historically represented by BASF, which ceased production of glufosinate active ingredient in Germany by the end of 2024. Since then, commercial technical active ingredient supply has become increasingly concentrated among Chinese producers, strengthening China's role in global manufacturing, cost optimization and export-oriented supply.

North America and Latin America are important downstream demand regions because of their large-scale agricultural sectors and established use of glufosinate-based weed-control systems. Europe and the rest of Asia-Pacific are relatively more fragmented, with demand shaped by local pesticide registrations, crop structures and formulation portfolios. In mature import markets, product consistency, supply reliability and registration support are increasingly important purchasing criteria, while emerging agricultural markets provide additional opportunities as L-glufosinate-based products become more widely available.

Competitive Landscape Analysis

The Biological Glufosinate-Ammonium technical market is relatively concentrated, with major participants during the study period including Lier Chemical, YongNong Biosciences, Zhejiang Xinan Chemical Industrial Group, Limin Group, Shandong Luba Chemical, Jiangsu Sevencontinent Green Chemical and BASF. BASF previously produced glufosinate active ingredient in Germany and ceased the relevant production by the end of 2024, after which commercial supply became further concentrated among Chinese producers. Competitive differentiation is driven less by individual technical-grade specifications and more by manufacturing scale, maturity of biocatalytic processes, upstream feedstock integration, production cost, product consistency, registration capability and customer relationships. Leading producers benefit from integrated raw-material and technical active ingredient manufacturing systems, while other established suppliers continue to strengthen their positions through process optimization, capacity development and customer expansion. As biological manufacturing becomes more widely commercialized, competition is expected to shift further toward enzyme efficiency, conversion yield, capacity utilization, integrated production economics and global supply capability.

Report Scope

This report is a detailed and comprehensive analysis for global Biological Glufosinate-Ammonium market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Biological Glufosinate-Ammonium market size and forecasts, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032

Global Biological Glufosinate-Ammonium market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032

Global Biological Glufosinate-Ammonium market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Tons), and average selling prices (US$/Ton), 2021-2032

Global Biological Glufosinate-Ammonium market shares of main players, shipments in revenue ($ Million), sales quantity (Tons), and ASP (US$/Ton), 2021-2026

The Primary Objectives in This Report Are:

• To determine the size of the total market opportunity of global and key countries
• To assess the growth potential for Biological Glufosinate-Ammonium
• To forecast future growth in each product and end-use market
• To assess competitive factors affecting the marketplace

This report profiles key players in the global Biological Glufosinate-Ammonium market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Lier Chemical, YongNong Biosciences, Zhejiang Xinan Chemical Industrial Group, Limin Group, Shandong Luba Chemical, Jiangsu Sevencontinent Green Chemical, BASF, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Biological Glufosinate-Ammonium market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market Segmentation

Market segment by Type

• Enzymatic Deracemization
• Fermentation-derived Chiral Precursor
• Other

Market segment by Technical Purity

• 90% Grade
• Above 90% Grade

Market segment by Feedstock Route

• Racemic Glufosinate-based
• L-Homoserine-based
• Other

Market segment by Application

• Field Crops
• Horticultural Crops
• Plantation & Forestry Crops
• Other

Major players covered

• Lier Chemical
• YongNong Biosciences
• Zhejiang Xinan Chemical Industrial Group
• Limin Group
• Shandong Luba Chemical
• Jiangsu Sevencontinent Green Chemical
• BASF

Market segment by region, regional analysis covers

• North America (United States, Canada, and Mexico)
• Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
• Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
• South America (Brazil, Argentina, Colombia, and Rest of South America)
• Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

Chapter Outline

Chapter 1, to describe Biological Glufosinate-Ammonium product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Biological Glufosinate-Ammonium, with price, sales quantity, revenue, and global market share of Biological Glufosinate-Ammonium from 2021 to 2026.

Chapter 3, the Biological Glufosinate-Ammonium competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Biological Glufosinate-Ammonium breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Biological Glufosinate-Ammonium market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Biological Glufosinate-Ammonium.

Chapter 14 and 15, to describe Biological Glufosinate-Ammonium sales channel, distributors, customers, research findings and conclusion.

Contents

1 MARKET OVERVIEW

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
  1.3.1 Overview: Global Biological Glufosinate-Ammonium Consumption Value by Type: 2021 Versus 2025 Versus 2032
  1.3.2 Enzymatic Deracemization
  1.3.3 Fermentation-derived Chiral Precursor
  1.3.4 Other
1.4 Market Analysis by Technical Purity
  1.4.1 Overview: Global Biological Glufosinate-Ammonium Consumption Value by Technical Purity: 2021 Versus 2025 Versus 2032
  1.4.2 90% Grade
  1.4.3 Above 90% Grade
1.5 Market Analysis by Feedstock Route
  1.5.1 Overview: Global Biological Glufosinate-Ammonium Consumption Value by Feedstock Route: 2021 Versus 2025 Versus 2032
  1.5.2 Racemic Glufosinate-based
  1.5.3 L-Homoserine-based
  1.5.4 Other
1.6 Market Analysis by Application
  1.6.1 Overview: Global Biological Glufosinate-Ammonium Consumption Value by Application: 2021 Versus 2025 Versus 2032
  1.6.2 Field Crops
  1.6.3 Horticultural Crops
  1.6.4 Plantation & Forestry Crops
  1.6.5 Other
1.7 Global Biological Glufosinate-Ammonium Market Size & Forecast
  1.7.1 Global Biological Glufosinate-Ammonium Consumption Value (2021 & 2025 & 2032)
  1.7.2 Global Biological Glufosinate-Ammonium Sales Quantity (2021-2032)
  1.7.3 Global Biological Glufosinate-Ammonium Average Price (2021-2032)

2 MANUFACTURERS PROFILES

2.1 Lier Chemical
  2.1.1 Lier Chemical Details
  2.1.2 Lier Chemical Major Business
  2.1.3 Lier Chemical Biological Glufosinate-Ammonium Product and Services
  2.1.4 Lier Chemical Biological Glufosinate-Ammonium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.1.5 Lier Chemical Recent Developments/Updates
2.2 YongNong Biosciences
  2.2.1 YongNong Biosciences Details
  2.2.2 YongNong Biosciences Major Business
  2.2.3 YongNong Biosciences Biological Glufosinate-Ammonium Product and Services
  2.2.4 YongNong Biosciences Biological Glufosinate-Ammonium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.2.5 YongNong Biosciences Recent Developments/Updates
2.3 Zhejiang Xinan Chemical Industrial Group
  2.3.1 Zhejiang Xinan Chemical Industrial Group Details
  2.3.2 Zhejiang Xinan Chemical Industrial Group Major Business
  2.3.3 Zhejiang Xinan Chemical Industrial Group Biological Glufosinate-Ammonium Product and Services
  2.3.4 Zhejiang Xinan Chemical Industrial Group Biological Glufosinate-Ammonium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.3.5 Zhejiang Xinan Chemical Industrial Group Recent Developments/Updates
2.4 Limin Group
  2.4.1 Limin Group Details
  2.4.2 Limin Group Major Business
  2.4.3 Limin Group Biological Glufosinate-Ammonium Product and Services
  2.4.4 Limin Group Biological Glufosinate-Ammonium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.4.5 Limin Group Recent Developments/Updates
2.5 Shandong Luba Chemical
  2.5.1 Shandong Luba Chemical Details
  2.5.2 Shandong Luba Chemical Major Business
  2.5.3 Shandong Luba Chemical Biological Glufosinate-Ammonium Product and Services
  2.5.4 Shandong Luba Chemical Biological Glufosinate-Ammonium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.5.5 Shandong Luba Chemical Recent Developments/Updates
2.6 Jiangsu Sevencontinent Green Chemical
  2.6.1 Jiangsu Sevencontinent Green Chemical Details
  2.6.2 Jiangsu Sevencontinent Green Chemical Major Business
  2.6.3 Jiangsu Sevencontinent Green Chemical Biological Glufosinate-Ammonium Product and Services
  2.6.4 Jiangsu Sevencontinent Green Chemical Biological Glufosinate-Ammonium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.6.5 Jiangsu Sevencontinent Green Chemical Recent Developments/Updates
2.7 BASF
  2.7.1 BASF Details
  2.7.2 BASF Major Business
  2.7.3 BASF Biological Glufosinate-Ammonium Product and Services
  2.7.4 BASF Biological Glufosinate-Ammonium Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
  2.7.5 BASF Recent Developments/Updates

3 COMPETITIVE ENVIRONMENT: BIOLOGICAL GLUFOSINATE-AMMONIUM BY MANUFACTURER

3.1 Global Biological Glufosinate-Ammonium Sales Quantity by Manufacturer (2021-2026)
3.2 Global Biological Glufosinate-Ammonium Revenue by Manufacturer (2021-2026)
3.3 Global Biological Glufosinate-Ammonium Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
  3.4.1 Producer Shipments of Biological Glufosinate-Ammonium by Manufacturer Revenue ($MM) and Market Share (%): 2025
  3.4.2 Top 3 Biological Glufosinate-Ammonium Manufacturer Market Share in 2025
  3.4.3 Top 6 Biological Glufosinate-Ammonium Manufacturer Market Share in 2025
3.5 Biological Glufosinate-Ammonium Market: Overall Company Footprint Analysis
  3.5.1 Biological Glufosinate-Ammonium Market: Region Footprint
  3.5.2 Biological Glufosinate-Ammonium Market: Company Product Type Footprint
  3.5.3 Biological Glufosinate-Ammonium Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 CONSUMPTION ANALYSIS BY REGION

4.1 Global Biological Glufosinate-Ammonium Market Size by Region
  4.1.1 Global Biological Glufosinate-Ammonium Sales Quantity by Region (2021-2032)
  4.1.2 Global Biological Glufosinate-Ammonium Consumption Value by Region (2021-2032)
  4.1.3 Global Biological Glufosinate-Ammonium Average Price by Region (2021-2032)
4.2 North America Biological Glufosinate-Ammonium Consumption Value (2021-2032)
4.3 Europe Biological Glufosinate-Ammonium Consumption Value (2021-2032)
4.4 Asia-Pacific Biological Glufosinate-Ammonium Consumption Value (2021-2032)
4.5 South America Biological Glufosinate-Ammonium Consumption Value (2021-2032)
4.6 Middle East & Africa Biological Glufosinate-Ammonium Consumption Value (2021-2032)

5 MARKET SEGMENT BY TYPE

5.1 Global Biological Glufosinate-Ammonium Sales Quantity by Type (2021-2032)
5.2 Global Biological Glufosinate-Ammonium Consumption Value by Type (2021-2032)
5.3 Global Biological Glufosinate-Ammonium Average Price by Type (2021-2032)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Biological Glufosinate-Ammonium Sales Quantity by Application (2021-2032)
6.2 Global Biological Glufosinate-Ammonium Consumption Value by Application (2021-2032)
6.3 Global Biological Glufosinate-Ammonium Average Price by Application (2021-2032)

7 NORTH AMERICA

7.1 North America Biological Glufosinate-Ammonium Sales Quantity by Type (2021-2032)
7.2 North America Biological Glufosinate-Ammonium Sales Quantity by Application (2021-2032)
7.3 North America Biological Glufosinate-Ammonium Market Size by Country
  7.3.1 North America Biological Glufosinate-Ammonium Sales Quantity by Country (2021-2032)
  7.3.2 North America Biological Glufosinate-Ammonium Consumption Value by Country (2021-2032)
  7.3.3 United States Market Size and Forecast (2021-2032)
  7.3.4 Canada Market Size and Forecast (2021-2032)
  7.3.5 Mexico Market Size and Forecast (2021-2032)

8 EUROPE

8.1 Europe Biological Glufosinate-Ammonium Sales Quantity by Type (2021-2032)
8.2 Europe Biological Glufosinate-Ammonium Sales Quantity by Application (2021-2032)
8.3 Europe Biological Glufosinate-Ammonium Market Size by Country
  8.3.1 Europe Biological Glufosinate-Ammonium Sales Quantity by Country (2021-2032)
  8.3.2 Europe Biological Glufosinate-Ammonium Consumption Value by Country (2021-2032)
  8.3.3 Germany Market Size and Forecast (2021-2032)
  8.3.4 France Market Size and Forecast (2021-2032)
  8.3.5 United Kingdom Market Size and Forecast (2021-2032)
  8.3.6 Russia Market Size and Forecast (2021-2032)
  8.3.7 Italy Market Size and Forecast (2021-2032)

9 ASIA-PACIFIC

9.1 Asia-Pacific Biological Glufosinate-Ammonium Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Biological Glufosinate-Ammonium Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Biological Glufosinate-Ammonium Market Size by Region
  9.3.1 Asia-Pacific Biological Glufosinate-Ammonium Sales Quantity by Region (2021-2032)
  9.3.2 Asia-Pacific Biological Glufosinate-Ammonium Consumption Value by Region (2021-2032)
  9.3.3 China Market Size and Forecast (2021-2032)
  9.3.4 Japan Market Size and Forecast (2021-2032)
  9.3.5 South Korea Market Size and Forecast (2021-2032)
  9.3.6 India Market Size and Forecast (2021-2032)
  9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
  9.3.8 Australia Market Size and Forecast (2021-2032)

10 SOUTH AMERICA

10.1 South America Biological Glufosinate-Ammonium Sales Quantity by Type (2021-2032)
10.2 South America Biological Glufosinate-Ammonium Sales Quantity by Application (2021-2032)
10.3 South America Biological Glufosinate-Ammonium Market Size by Country
  10.3.1 South America Biological Glufosinate-Ammonium Sales Quantity by Country (2021-2032)
  10.3.2 South America Biological Glufosinate-Ammonium Consumption Value by Country (2021-2032)
  10.3.3 Brazil Market Size and Forecast (2021-2032)
  10.3.4 Argentina Market Size and Forecast (2021-2032)

11 MIDDLE EAST & AFRICA

11.1 Middle East & Africa Biological Glufosinate-Ammonium Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Biological Glufosinate-Ammonium Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Biological Glufosinate-Ammonium Market Size by Country
  11.3.1 Middle East & Africa Biological Glufosinate-Ammonium Sales Quantity by Country (2021-2032)
  11.3.2 Middle East & Africa Biological Glufosinate-Ammonium Consumption Value by Country (2021-2032)
  11.3.3 Turkey Market Size and Forecast (2021-2032)
  11.3.4 Egypt Market Size and Forecast (2021-2032)
  11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
  11.3.6 South Africa Market Size and Forecast (2021-2032)

12 MARKET DYNAMICS

12.1 Biological Glufosinate-Ammonium Market Drivers
12.2 Biological Glufosinate-Ammonium Market Restraints
12.3 Biological Glufosinate-Ammonium Trends Analysis
12.4 Porters Five Forces Analysis
  12.4.1 Threat of New Entrants
  12.4.2 Bargaining Power of Suppliers
  12.4.3 Bargaining Power of Buyers
  12.4.4 Threat of Substitutes
  12.4.5 Competitive Rivalry

13 RAW MATERIAL AND INDUSTRY CHAIN

13.1 Raw Material of Biological Glufosinate-Ammonium and Key Manufacturers
13.2 Manufacturing Costs Percentage of Biological Glufosinate-Ammonium
13.3 Biological Glufosinate-Ammonium Production Process
13.4 Industry Value Chain Analysis

14 SHIPMENTS BY DISTRIBUTION CHANNEL

14.1 Sales Channel
  14.1.1 Direct to End-User
  14.1.2 Distributors
14.2 Biological Glufosinate-Ammonium Typical Distributors
14.3 Biological Glufosinate-Ammonium Typical Customers

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Global Biological Glufosinate-Ammonium Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Biological Glufosinate-Ammonium Consumption Value by Technical Purity, (USD Million), 2021 & 2025 & 2032
Table 3. Global Biological Glufosinate-Ammonium Consumption Value by Feedstock Route, (USD Million), 2021 & 2025 & 2032
Table 4. Global Biological Glufosinate-Ammonium Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Lier Chemical Basic Information, Manufacturing Base and Competitors
Table 6. Lier Chemical Major Business
Table 7. Lier Chemical Biological Glufosinate-Ammonium Product and Services
Table 8. Lier Chemical Biological Glufosinate-Ammonium Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 9. Lier Chemical Recent Developments/Updates
Table 10. YongNong Biosciences Basic Information, Manufacturing Base and Competitors
Table 11. YongNong Biosciences Major Business
Table 12. YongNong Biosciences Biological Glufosinate-Ammonium Product and Services
Table 13. YongNong Biosciences Biological Glufosinate-Ammonium Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 14. YongNong Biosciences Recent Developments/Updates
Table 15. Zhejiang Xinan Chemical Industrial Group Basic Information, Manufacturing Base and Competitors
Table 16. Zhejiang Xinan Chemical Industrial Group Major Business
Table 17. Zhejiang Xinan Chemical Industrial Group Biological Glufosinate-Ammonium Product and Services
Table 18. Zhejiang Xinan Chemical Industrial Group Biological Glufosinate-Ammonium Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 19. Zhejiang Xinan Chemical Industrial Group Recent Developments/Updates
Table 20. Limin Group Basic Information, Manufacturing Base and Competitors
Table 21. Limin Group Major Business
Table 22. Limin Group Biological Glufosinate-Ammonium Product and Services
Table 23. Limin Group Biological Glufosinate-Ammonium Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 24. Limin Group Recent Developments/Updates
Table 25. Shandong Luba Chemical Basic Information, Manufacturing Base and Competitors
Table 26. Shandong Luba Chemical Major Business
Table 27. Shandong Luba Chemical Biological Glufosinate-Ammonium Product and Services
Table 28. Shandong Luba Chemical Biological Glufosinate-Ammonium Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 29. Shandong Luba Chemical Recent Developments/Updates
Table 30. Jiangsu Sevencontinent Green Chemical Basic Information, Manufacturing Base and Competitors
Table 31. Jiangsu Sevencontinent Green Chemical Major Business
Table 32. Jiangsu Sevencontinent Green Chemical Biological Glufosinate-Ammonium Product and Services
Table 33. Jiangsu Sevencontinent Green Chemical Biological Glufosinate-Ammonium Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 34. Jiangsu Sevencontinent Green Chemical Recent Developments/Updates
Table 35. BASF Basic Information, Manufacturing Base and Competitors
Table 36. BASF Major Business
Table 37. BASF Biological Glufosinate-Ammonium Product and Services
Table 38. BASF Biological Glufosinate-Ammonium Sales Quantity (Tons), Average Price (US$/Ton), Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 39. BASF Recent Developments/Updates
Table 40. Global Biological Glufosinate-Ammonium Sales Quantity by Manufacturer (2021-2026) & (Tons)
Table 41. Global Biological Glufosinate-Ammonium Revenue by Manufacturer (2021-2026) & (USD Million)
Table 42. Global Biological Glufosinate-Ammonium Average Price by Manufacturer (2021-2026) & (US$/Ton)
Table 43. Market Position of Manufacturers in Biological Glufosinate-Ammonium, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 44. Head Office and Biological Glufosinate-Ammonium Production Site of Key Manufacturer
Table 45. Biological Glufosinate-Ammonium Market: Company Product Type Footprint
Table 46. Biological Glufosinate-Ammonium Market: Company Product Application Footprint
Table 47. Biological Glufosinate-Ammonium New Market Entrants and Barriers to Market Entry
Table 48. Biological Glufosinate-Ammonium Mergers, Acquisition, Agreements, and Collaborations
Table 49. Global Biological Glufosinate-Ammonium Consumption Value by Region (2021-2025-2032) & (USD Million) & CAGR
Table 50. Global Biological Glufosinate-Ammonium Sales Quantity by Region (2021-2026) & (Tons)
Table 51. Global Biological Glufosinate-Ammonium Sales Quantity by Region (2027-2032) & (Tons)
Table 52. Global Biological Glufosinate-Ammonium Consumption Value by Region (2021-2026) & (USD Million)
Table 53. Global Biological Glufosinate-Ammonium Consumption Value by Region (2027-2032) & (USD Million)
Table 54. Global Biological Glufosinate-Ammonium Average Price by Region (2021-2026) & (US$/Ton)
Table 55. Global Biological Glufosinate-Ammonium Average Price by Region (2027-2032) & (US$/Ton)
Table 56. Global Biological Glufosinate-Ammonium Sales Quantity by Type (2021-2026) & (Tons)
Table 57. Global Biological Glufosinate-Ammonium Sales Quantity by Type (2027-2032) & (Tons)
Table 58. Global Biological Glufosinate-Ammonium Consumption Value by Type (2021-2026) & (USD Million)
Table 59. Global Biological Glufosinate-Ammonium Consumption Value by Type (2027-2032) & (USD Million)
Table 60. Global Biological Glufosinate-Ammonium Average Price by Type (2021-2026) & (US$/Ton)
Table 61. Global Biological Glufosinate-Ammonium Average Price by Type (2027-2032) & (US$/Ton)
Table 62. Global Biological Glufosinate-Ammonium Sales Quantity by Application (2021-2026) & (Tons)
Table 63. Global Biological Glufosinate-Ammonium Sales Quantity by Application (2027-2032) & (Tons)
Table 64. Global Biological Glufosinate-Ammonium Consumption Value by Application (2021-2026) & (USD Million)
Table 65. Global Biological Glufosinate-Ammonium Consumption Value by Application (2027-2032) & (USD Million)
Table 66. Global Biological Glufosinate-Ammonium Average Price by Application (2021-2026) & (US$/Ton)
Table 67. Global Biological Glufosinate-Ammonium Average Price by Application (2027-2032) & (US$/Ton)
Table 68. North America Biological Glufosinate-Ammonium Sales Quantity by Type (2021-2026) & (Tons)
Table 69. North America Biological Glufosinate-Ammonium Sales Quantity by Type (2027-2032) & (Tons)
Table 70. North America Biological Glufosinate-Ammonium Sales Quantity by Application (2021-2026) & (Tons)
Table 71. North America Biological Glufosinate-Ammonium Sales Quantity by Application (2027-2032) & (Tons)
Table 72. North America Biological Glufosinate-Ammonium Sales Quantity by Country (2021-2026) & (Tons)
Table 73. North America Biological Glufosinate-Ammonium Sales Quantity by Country (2027-2032) & (Tons)
Table 74. North America Biological Glufosinate-Ammonium Consumption Value by Country (2021-2026) & (USD Million)
Table 75. North America Biological Glufosinate-Ammonium Consumption Value by Country (2027-2032) & (USD Million)
Table 76. Europe Biological Glufosinate-Ammonium Sales Quantity by Type (2021-2026) & (Tons)
Table 77. Europe Biological Glufosinate-Ammonium Sales Quantity by Type (2027-2032) & (Tons)
Table 78. Europe Biological Glufosinate-Ammonium Sales Quantity by Application (2021-2026) & (Tons)
Table 79. Europe Biological Glufosinate-Ammonium Sales Quantity by Application (2027-2032) & (Tons)
Table 80. Europe Biological Glufosinate-Ammonium Sales Quantity by Country (2021-2026) & (Tons)
Table 81. Europe Biological Glufosinate-Ammonium Sales Quantity by Country (2027-2032) & (Tons)
Table 82. Europe Biological Glufosinate-Ammonium Consumption Value by Country (2021-2026) & (USD Million)
Table 83. Europe Biological Glufosinate-Ammonium Consumption Value by Country (2027-2032) & (USD Million)
Table 84. Asia-Pacific Biological Glufosinate-Ammonium Sales Quantity by Type (2021-2026) & (Tons)
Table 85. Asia-Pacific Biological Glufosinate-Ammonium Sales Quantity by Type (2027-2032) & (Tons)
Table 86. Asia-Pacific Biological Glufosinate-Ammonium Sales Quantity by Application (2021-2026) & (Tons)
Table 87. Asia-Pacific Biological Glufosinate-Ammonium Sales Quantity by Application (2027-2032) & (Tons)
Table 88. Asia-Pacific Biological Glufosinate-Ammonium Sales Quantity by Region (2021-2026) & (Tons)
Table 89. Asia-Pacific Biological Glufosinate-Ammonium Sales Quantity by Region (2027-2032) & (Tons)
Table 90. Asia-Pacific Biological Glufosinate-Ammonium Consumption Value by Region (2021-2026) & (USD Million)
Table 91. Asia-Pacific Biological Glufosinate-Ammonium Consumption Value by Region (2027-2032) & (USD Million)
Table 92. South America Biological Glufosinate-Ammonium Sales Quantity by Type (2021-2026) & (Tons)
Table 93. South America Biological Glufosinate-Ammonium Sales Quantity by Type (2027-2032) & (Tons)
Table 94. South America Biological Glufosinate-Ammonium Sales Quantity by Application (2021-2026) & (Tons)
Table 95. South America Biological Glufosinate-Ammonium Sales Quantity by Application (2027-2032) & (Tons)
Table 96. South America Biological Glufosinate-Ammonium Sales Quantity by Country (2021-2026) & (Tons)
Table 97. South America Biological Glufosinate-Ammonium Sales Quantity by Country (2027-2032) & (Tons)
Table 98. South America Biological Glufosinate-Ammonium Consumption Value by Country (2021-2026) & (USD Million)
Table 99. South America Biological Glufosinate-Ammonium Consumption Value by Country (2027-2032) & (USD Million)
Table 100. Middle East & Africa Biological Glufosinate-Ammonium Sales Quantity by Type (2021-2026) & (Tons)
Table 101. Middle East & Africa Biological Glufosinate-Ammonium Sales Quantity by Type (2027-2032) & (Tons)
Table 102. Middle East & Africa Biological Glufosinate-Ammonium Sales Quantity by Application (2021-2026) & (Tons)
Table 103. Middle East & Africa Biological Glufosinate-Ammonium Sales Quantity by Application (2027-2032) & (Tons)
Table 104. Middle East & Africa Biological Glufosinate-Ammonium Sales Quantity by Country (2021-2026) & (Tons)
Table 105. Middle East & Africa Biological Glufosinate-Ammonium Sales Quantity by Country (2027-2032) & (Tons)
Table 106. Middle East & Africa Biological Glufosinate-Ammonium Consumption Value by Country (2021-2026) & (USD Million)
Table 107. Middle East & Africa Biological Glufosinate-Ammonium Consumption Value by Country (2027-2032) & (USD Million)
Table 108. Biological Glufosinate-Ammonium Raw Material
Table 109. Key Manufacturers of Biological Glufosinate-Ammonium Raw Materials
Table 110. Biological Glufosinate-Ammonium Typical Distributors
Table 111. Biological Glufosinate-Ammonium Typical Customers

List Of Figures

LIST OF FIGURES

Figure 1. Biological Glufosinate-Ammonium Picture
Figure 2. Global Biological Glufosinate-Ammonium Revenue by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Biological Glufosinate-Ammonium Revenue Market Share by Type in 2025
Figure 4. Enzymatic Deracemization Examples
Figure 5. Fermentation-derived Chiral Precursor Examples
Figure 6. Other Examples
Figure 7. Global Biological Glufosinate-Ammonium Revenue by Technical Purity, (USD Million), 2021 & 2025 & 2032
Figure 8. Global Biological Glufosinate-Ammonium Revenue Market Share by Technical Purity in 2025
Figure 9. 90% Grade Examples
Figure 10. Above 90% Grade Examples
Figure 11. Global Biological Glufosinate-Ammonium Revenue by Feedstock Route, (USD Million), 2021 & 2025 & 2032
Figure 12. Global Biological Glufosinate-Ammonium Revenue Market Share by Feedstock Route in 2025
Figure 13. Racemic Glufosinate-based Examples
Figure 14. L-Homoserine-based Examples
Figure 15. Other Examples
Figure 16. Global Biological Glufosinate-Ammonium Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 17. Global Biological Glufosinate-Ammonium Revenue Market Share by Application in 2025
Figure 18. Field Crops Examples
Figure 19. Horticultural Crops Examples
Figure 20. Plantation & Forestry Crops Examples
Figure 21. Other Examples
Figure 22. Global Biological Glufosinate-Ammonium Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 23. Global Biological Glufosinate-Ammonium Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 24. Global Biological Glufosinate-Ammonium Sales Quantity (2021-2032) & (Tons)
Figure 25. Global Biological Glufosinate-Ammonium Price (2021-2032) & (US$/Ton)
Figure 26. Global Biological Glufosinate-Ammonium Sales Quantity Market Share by Manufacturer in 2025
Figure 27. Global Biological Glufosinate-Ammonium Revenue Market Share by Manufacturer in 2025
Figure 28. Producer Shipments of Biological Glufosinate-Ammonium by Manufacturer Sales ($MM) and Market Share (%): 2025
Figure 29. Top 3 Biological Glufosinate-Ammonium Manufacturer (Revenue) Market Share in 2025
Figure 30. Top 6 Biological Glufosinate-Ammonium Manufacturer (Revenue) Market Share in 2025
Figure 31. Global Biological Glufosinate-Ammonium Sales Quantity Market Share by Region (2021-2032)
Figure 32. Global Biological Glufosinate-Ammonium Consumption Value Market Share by Region (2021-2032)
Figure 33. North America Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 34. Europe Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 35. Asia-Pacific Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 36. South America Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 37. Middle East & Africa Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 38. Global Biological Glufosinate-Ammonium Sales Quantity Market Share by Type (2021-2032)
Figure 39. Global Biological Glufosinate-Ammonium Consumption Value Market Share by Type (2021-2032)
Figure 40. Global Biological Glufosinate-Ammonium Average Price by Type (2021-2032) & (US$/Ton)
Figure 41. Global Biological Glufosinate-Ammonium Sales Quantity Market Share by Application (2021-2032)
Figure 42. Global Biological Glufosinate-Ammonium Revenue Market Share by Application (2021-2032)
Figure 43. Global Biological Glufosinate-Ammonium Average Price by Application (2021-2032) & (US$/Ton)
Figure 44. North America Biological Glufosinate-Ammonium Sales Quantity Market Share by Type (2021-2032)
Figure 45. North America Biological Glufosinate-Ammonium Sales Quantity Market Share by Application (2021-2032)
Figure 46. North America Biological Glufosinate-Ammonium Sales Quantity Market Share by Country (2021-2032)
Figure 47. North America Biological Glufosinate-Ammonium Consumption Value Market Share by Country (2021-2032)
Figure 48. United States Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 49. Canada Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 50. Mexico Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 51. Europe Biological Glufosinate-Ammonium Sales Quantity Market Share by Type (2021-2032)
Figure 52. Europe Biological Glufosinate-Ammonium Sales Quantity Market Share by Application (2021-2032)
Figure 53. Europe Biological Glufosinate-Ammonium Sales Quantity Market Share by Country (2021-2032)
Figure 54. Europe Biological Glufosinate-Ammonium Consumption Value Market Share by Country (2021-2032)
Figure 55. Germany Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 56. France Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 57. United Kingdom Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 58. Russia Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 59. Italy Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 60. Asia-Pacific Biological Glufosinate-Ammonium Sales Quantity Market Share by Type (2021-2032)
Figure 61. Asia-Pacific Biological Glufosinate-Ammonium Sales Quantity Market Share by Application (2021-2032)
Figure 62. Asia-Pacific Biological Glufosinate-Ammonium Sales Quantity Market Share by Region (2021-2032)
Figure 63. Asia-Pacific Biological Glufosinate-Ammonium Consumption Value Market Share by Region (2021-2032)
Figure 64. China Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 65. Japan Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 66. South Korea Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 67. India Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 68. Southeast Asia Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 69. Australia Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 70. South America Biological Glufosinate-Ammonium Sales Quantity Market Share by Type (2021-2032)
Figure 71. South America Biological Glufosinate-Ammonium Sales Quantity Market Share by Application (2021-2032)
Figure 72. South America Biological Glufosinate-Ammonium Sales Quantity Market Share by Country (2021-2032)
Figure 73. South America Biological Glufosinate-Ammonium Consumption Value Market Share by Country (2021-2032)
Figure 74. Brazil Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 75. Argentina Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 76. Middle East & Africa Biological Glufosinate-Ammonium Sales Quantity Market Share by Type (2021-2032)
Figure 77. Middle East & Africa Biological Glufosinate-Ammonium Sales Quantity Market Share by Application (2021-2032)
Figure 78. Middle East & Africa Biological Glufosinate-Ammonium Sales Quantity Market Share by Country (2021-2032)
Figure 79. Middle East & Africa Biological Glufosinate-Ammonium Consumption Value Market Share by Country (2021-2032)
Figure 80. Turkey Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 81. Egypt Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 82. Saudi Arabia Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 83. South Africa Biological Glufosinate-Ammonium Consumption Value (2021-2032) & (USD Million)
Figure 84. Biological Glufosinate-Ammonium Market Drivers
Figure 85. Biological Glufosinate-Ammonium Market Restraints
Figure 86. Biological Glufosinate-Ammonium Market Trends
Figure 87. Porters Five Forces Analysis
Figure 88. Manufacturing Cost Structure Analysis of Biological Glufosinate-Ammonium in 2025
Figure 89. Manufacturing Process Analysis of Biological Glufosinate-Ammonium
Figure 90. Biological Glufosinate-Ammonium Industrial Chain
Figure 91. Sales Channel: Direct to End-User vs Distributors
Figure 92. Direct Channel Pros & Cons
Figure 93. Indirect Channel Pros & Cons
Figure 94. Methodology
Figure 95. Research Process and Data Source